
Eli Lilly's weight loss drugs drive 39% revenue surge, fueling strong growth outlook.
Eli Lilly has seen its revenue soar thanks to its dominance in the weight loss drug market, with products like Mounjaro and Zepbound contributing to a 39% revenue increase to over $24 billion recently. The company leads in GLP-1 drugs, which regulate...





